Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of EV71 inactivated vaccine (Vero cell) in children 6–71 months
CTR20182296Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of enterovirus 71 vaccine (vero cell), inactivated, sponsored by Sinovac Biotech Ltd.. Started Dec 2018; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
Beyond the preview
Go deeper on CTR20182296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182296.